🚀 VC round data is live in beta, check it out!
Medicon Hellas Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medicon Hellas and similar public comparables like BioLineRx, Biogened, Chemomab Therapeutics, Abera Bioscience and more.
Medicon Hellas Overview
About Medicon Hellas
Medicon Hellas SA is a manufacturer of diagnostic reagent kits, and bulk reagents and a re-manufacturer of Olympus, Nihon Kohden, and Siemens analyzers. The company's services include Refurbishment, informatics, and Diagnostic Labs.
Founded
1998
HQ
Employees
175
Website
Sectors
Financials (FY)
EV
$13M
Medicon Hellas Stock Performance
Medicon Hellas has current market cap of $13M, and enterprise value of $13M.
Market Cap Evolution
Medicon Hellas' stock price is $2.88.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $13M | (0.2%) | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedicon Hellas Valuation Multiples
Medicon Hellas Financial Valuation Multiples
As of March 7, 2026, Medicon Hellas has market cap of $13M and EV of $13M.
Equity research analysts estimate Medicon Hellas' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV (current) | $13M | XXX | $13M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medicon Hellas Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medicon Hellas Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| BioLineRx | XXX | XXX | XXX | XXX | XXX | XXX |
| Biogened | XXX | XXX | XXX | XXX | XXX | XXX |
| Chemomab Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Abera Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Annexin Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medicon Hellas M&A Activity
Medicon Hellas acquired XXX companies to date.
Last acquisition by Medicon Hellas was on XXXXXXXX, XXXXX. Medicon Hellas acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Medicon Hellas
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedicon Hellas Investment Activity
Medicon Hellas invested in XXX companies to date.
Medicon Hellas made its latest investment on XXXXXXXX, XXXXX. Medicon Hellas invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Medicon Hellas
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medicon Hellas
| When was Medicon Hellas founded? | Medicon Hellas was founded in 1998. |
| Where is Medicon Hellas headquartered? | Medicon Hellas is headquartered in Greece. |
| How many employees does Medicon Hellas have? | As of today, Medicon Hellas has over 175 employees. |
| Is Medicon Hellas publicly listed? | Yes, Medicon Hellas is a public company listed on Athens Stock Exchange. |
| What is the stock symbol of Medicon Hellas? | Medicon Hellas trades under MEDIC ticker. |
| When did Medicon Hellas go public? | Medicon Hellas went public in 2001. |
| Who are competitors of Medicon Hellas? | Medicon Hellas main competitors are BioLineRx, Biogened, Chemomab Therapeutics, Abera Bioscience. |
| What is the current market cap of Medicon Hellas? | Medicon Hellas' current market cap is $13M. |
| Is Medicon Hellas profitable? | No, Medicon Hellas is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.